Copyright Reports & Markets. All rights reserved.

Global Radiopharmaceutical Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Radiopharmaceutical Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type
    • 1.2.2 Actinium-225
    • 1.2.3 Lutetium-177
    • 1.2.4 Radium-223
    • 1.2.5 Holmium-166
    • 1.2.6 Other
  • 1.3 Market by Application
    • 1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application
    • 1.3.2 Oncology
    • 1.3.3 Cardiology
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Radiopharmaceutical Market Size Estimates and Forecasts
    • 2.1.1 Global Radiopharmaceutical Revenue 2015-2026
    • 2.1.2 Global Radiopharmaceutical Sales 2015-2026
  • 2.2 Radiopharmaceutical Market Size by Region: 2020 Versus 2026
  • 2.3 Radiopharmaceutical Sales by Region (2015-2026)
    • 2.3.1 Global Radiopharmaceutical Sales by Region: 2015-2020
    • 2.3.2 Global Radiopharmaceutical Sales Forecast by Region (2021-2026)
    • 2.3.3 Global Radiopharmaceutical Sales Market Share by Region (2015-2026)
  • 2.4 Radiopharmaceutical Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Radiopharmaceutical Revenue by Region: 2015-2020
    • 2.4.2 Global Radiopharmaceutical Revenue Forecast by Region (2021-2026)
    • 2.4.3 Global Radiopharmaceutical Revenue Market Share by Region (2015-2026)

3 Global Radiopharmaceutical by Manufacturers

  • 3.1 Global Top Radiopharmaceutical Manufacturers by Sales
    • 3.1.1 Global Radiopharmaceutical Sales by Manufacturer (2015-2020)
    • 3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturer (2015-2019)
  • 3.2 Global Top Radiopharmaceutical Manufacturers by Revenue
    • 3.2.1 Global Radiopharmaceutical Revenue by Manufacturer (2015-2020)
    • 3.2.2 Global Radiopharmaceutical Revenue Share by Manufacturer (2015-2020)
  • 3.3 Global Radiopharmaceutical Price by Manufacturer (2015-2020)
  • 3.4 Competitive Landscape
    • 3.4.1 Key Radiopharmaceutical Manufacturers Covered: Ranking by Revenue
    • 3.4.2 Global Radiopharmaceutical Market Concentration Ratio (CR5 and HHI) & (2015-2020)
    • 3.4.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.5 Global Radiopharmaceutical Manufacturing Base Distribution, Product Type
    • 3.5.1 Radiopharmaceutical Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.5.2 Manufacturers Radiopharmaceutical Product Type
    • 3.5.3 Date of International Manufacturers Enter into Radiopharmaceutical Market
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

  • 4.1 Bracco Imaging
    • 4.1.1 Bracco Imaging Corporation Information
    • 4.1.2 Bracco Imaging Description, Business Overview
    • 4.1.3 Bracco Imaging Radiopharmaceutical Products Offered
    • 4.1.4 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.1.5 Bracco Imaging Radiopharmaceutical Revenue by Product
    • 4.1.6 Bracco Imaging Radiopharmaceutical Revenue by Application
    • 4.1.7 Bracco Imaging Radiopharmaceutical Revenue by Geographic Area
    • 4.1.8 Bracco Imaging Radiopharmaceutical Revenue by Sales Channel
    • 4.1.9 Bracco Imaging Recent Development
  • 4.2 Bayer
    • 4.2.1 Bayer Corporation Information
    • 4.2.2 Bayer Description, Business Overview
    • 4.2.3 Bayer Radiopharmaceutical Products Offered
    • 4.2.4 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.2.5 Bayer Radiopharmaceutical Revenue by Product
    • 4.2.6 Bayer Radiopharmaceutical Revenue by Application
    • 4.2.7 Bayer Radiopharmaceutical Revenue by Geographic Area
    • 4.2.8 Bayer Radiopharmaceutical Revenue by Sales Channel
    • 4.2.9 Bayer Recent Development
  • 4.3 Mallinckrodt
    • 4.3.1 Mallinckrodt Corporation Information
    • 4.3.2 Mallinckrodt Description, Business Overview
    • 4.3.3 Mallinckrodt Radiopharmaceutical Products Offered
    • 4.3.4 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.3.5 Mallinckrodt Radiopharmaceutical Revenue by Product
    • 4.3.6 Mallinckrodt Radiopharmaceutical Revenue by Application
    • 4.3.7 Mallinckrodt Radiopharmaceutical Revenue by Geographic Area
    • 4.3.8 Mallinckrodt Radiopharmaceutical Revenue by Sales Channel
    • 4.3.9 Mallinckrodt Recent Development
  • 4.4 Nordion
    • 4.4.1 Nordion Corporation Information
    • 4.4.2 Nordion Description, Business Overview
    • 4.4.3 Nordion Radiopharmaceutical Products Offered
    • 4.4.4 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.4.5 Nordion Radiopharmaceutical Revenue by Product
    • 4.4.6 Nordion Radiopharmaceutical Revenue by Application
    • 4.4.7 Nordion Radiopharmaceutical Revenue by Geographic Area
    • 4.4.8 Nordion Radiopharmaceutical Revenue by Sales Channel
    • 4.4.9 Nordion Recent Development
  • 4.5 Triad Isotopes
    • 4.5.1 Triad Isotopes Corporation Information
    • 4.5.2 Triad Isotopes Description, Business Overview
    • 4.5.3 Triad Isotopes Radiopharmaceutical Products Offered
    • 4.5.4 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.5.5 Triad Isotopes Radiopharmaceutical Revenue by Product
    • 4.5.6 Triad Isotopes Radiopharmaceutical Revenue by Application
    • 4.5.7 Triad Isotopes Radiopharmaceutical Revenue by Geographic Area
    • 4.5.8 Triad Isotopes Radiopharmaceutical Revenue by Sales Channel
    • 4.5.9 Triad Isotopes Recent Development
  • 4.6 Lantheus
    • 4.6.1 Lantheus Corporation Information
    • 4.6.2 Lantheus Description, Business Overview
    • 4.6.3 Lantheus Radiopharmaceutical Products Offered
    • 4.6.4 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.6.5 Lantheus Radiopharmaceutical Revenue by Product
    • 4.6.6 Lantheus Radiopharmaceutical Revenue by Application
    • 4.6.7 Lantheus Radiopharmaceutical Revenue by Geographic Area
    • 4.6.8 Lantheus Recent Development
  • 4.7 IBA Group
    • 4.7.1 IBA Group Corporation Information
    • 4.7.2 IBA Group Description, Business Overview
    • 4.7.3 IBA Group Radiopharmaceutical Products Offered
    • 4.7.4 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.7.5 IBA Group Radiopharmaceutical Revenue by Product
    • 4.7.6 IBA Group Radiopharmaceutical Revenue by Application
    • 4.7.7 IBA Group Radiopharmaceutical Revenue by Geographic Area
    • 4.7.8 IBA Group Recent Development
  • 4.8 GE Healthcare
    • 4.8.1 GE Healthcare Corporation Information
    • 4.8.2 GE Healthcare Description, Business Overview
    • 4.8.3 GE Healthcare Radiopharmaceutical Products Offered
    • 4.8.4 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.8.5 GE Healthcare Radiopharmaceutical Revenue by Product
    • 4.8.6 GE Healthcare Radiopharmaceutical Revenue by Application
    • 4.8.7 GE Healthcare Radiopharmaceutical Revenue by Geographic Area
    • 4.8.8 GE Healthcare Recent Development
  • 4.9 China Isotope & Radiation
    • 4.9.1 China Isotope & Radiation Corporation Information
    • 4.9.2 China Isotope & Radiation Description, Business Overview
    • 4.9.3 China Isotope & Radiation Radiopharmaceutical Products Offered
    • 4.9.4 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.9.5 China Isotope & Radiation Radiopharmaceutical Revenue by Product
    • 4.9.6 China Isotope & Radiation Radiopharmaceutical Revenue by Application
    • 4.9.7 China Isotope & Radiation Radiopharmaceutical Revenue by Geographic Area
    • 4.9.8 China Isotope & Radiation Recent Development
  • 4.10 Jubilant Pharma
    • 4.10.1 Jubilant Pharma Corporation Information
    • 4.10.2 Jubilant Pharma Description, Business Overview
    • 4.10.3 Jubilant Pharma Radiopharmaceutical Products Offered
    • 4.10.4 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.10.5 Jubilant Pharma Radiopharmaceutical Revenue by Product
    • 4.10.6 Jubilant Pharma Radiopharmaceutical Revenue by Application
    • 4.10.7 Jubilant Pharma Radiopharmaceutical Revenue by Geographic Area
    • 4.10.8 Jubilant Pharma Recent Development
  • 4.11 Eli Lilly
    • 4.11.1 Eli Lilly Corporation Information
    • 4.11.2 Eli Lilly Description, Business Overview
    • 4.11.3 Eli Lilly Radiopharmaceutical Products Offered
    • 4.11.4 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.11.5 Eli Lilly Radiopharmaceutical Revenue by Product
    • 4.11.6 Eli Lilly Radiopharmaceutical Revenue by Application
    • 4.11.7 Eli Lilly Radiopharmaceutical Revenue by Geographic Area
    • 4.11.8 Eli Lilly Recent Development
  • 4.12 Advanced Accelerator Applications
    • 4.12.1 Advanced Accelerator Applications Corporation Information
    • 4.12.2 Advanced Accelerator Applications Description, Business Overview
    • 4.12.3 Advanced Accelerator Applications Radiopharmaceutical Products Offered
    • 4.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.12.5 Advanced Accelerator Applications Radiopharmaceutical Revenue by Product
    • 4.12.6 Advanced Accelerator Applications Radiopharmaceutical Revenue by Application
    • 4.12.7 Advanced Accelerator Applications Radiopharmaceutical Revenue by Geographic Area
    • 4.12.8 Advanced Accelerator Applications Recent Development
  • 4.13 SIEMENS
    • 4.13.1 SIEMENS Corporation Information
    • 4.13.2 SIEMENS Description, Business Overview
    • 4.13.3 SIEMENS Radiopharmaceutical Products Offered
    • 4.13.4 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.13.5 SIEMENS Radiopharmaceutical Revenue by Product
    • 4.13.6 SIEMENS Radiopharmaceutical Revenue by Application
    • 4.13.7 SIEMENS Radiopharmaceutical Revenue by Geographic Area
    • 4.13.8 SIEMENS Recent Development
  • 4.14 Dongcheng
    • 4.14.1 Dongcheng Corporation Information
    • 4.14.2 Dongcheng Description, Business Overview
    • 4.14.3 Dongcheng Radiopharmaceutical Products Offered
    • 4.14.4 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.14.5 Dongcheng Radiopharmaceutical Revenue by Product
    • 4.14.6 Dongcheng Radiopharmaceutical Revenue by Application
    • 4.14.7 Dongcheng Radiopharmaceutical Revenue by Geographic Area
    • 4.14.8 Dongcheng Recent Development
  • 4.15 Navidea
    • 4.15.1 Navidea Corporation Information
    • 4.15.2 Navidea Description, Business Overview
    • 4.15.3 Navidea Radiopharmaceutical Products Offered
    • 4.15.4 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 4.15.5 Navidea Radiopharmaceutical Revenue by Product
    • 4.15.6 Navidea Radiopharmaceutical Revenue by Application
    • 4.15.7 Navidea Radiopharmaceutical Revenue by Geographic Area
    • 4.15.8 Navidea Recent Development

5 Breakdown Data by Type

  • 5.1 Global Radiopharmaceutical Sales by Type (2015-2026)
    • 5.1.1 Global Radiopharmaceutical Sales by Type (2015-2020)
    • 5.1.2 Global Radiopharmaceutical Sales Forecast by Type (2021-2026)
    • 5.1.3 Global Radiopharmaceutical Sales Market Share by Type (2015-2026)
  • 5.2 Global Radiopharmaceutical Revenue Forecast by Type (2015-2026)
    • 5.2.1 Global Radiopharmaceutical Revenue by Type (2015-2020)
    • 5.2.2 Global Radiopharmaceutical Revenue Forecast by Type (2021-2026)
    • 5.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2015-2026)
  • 5.3 Radiopharmaceutical Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

  • 6.1 Global Radiopharmaceutical Sales by Application (2015-2026)
    • 6.1.1 Global Radiopharmaceutical Sales by Application (2015-2020)
    • 6.1.2 Global Radiopharmaceutical Sales Forecast by Application (2021-2026)
    • 6.1.3 Global Radiopharmaceutical Sales Market Share by Application (2015-2026)
  • 6.2 Global Radiopharmaceutical Revenue Forecast by Application (2015-2026)
    • 6.2.1 Global Radiopharmaceutical Revenue by Application (2015-2020)
    • 6.2.2 Global Radiopharmaceutical Revenue Forecast by Application (2021-2026)
    • 6.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2015-2026)
  • 6.3 Radiopharmaceutical Average Selling Price (ASP) by Application (2015-2026)

7 North America

  • 7.1 North America Radiopharmaceutical Market Size YoY Growth 2015-2026
  • 7.2 North America Radiopharmaceutical Market Facts & Figures by Country
    • 7.2.1 North America Radiopharmaceutical Sales by Country (2015-2026)
    • 7.2.2 North America Radiopharmaceutical Revenue by Country (2015-2026)
  • 7.3 North America Radiopharmaceutical Sales by Type
  • 7.4 North America Radiopharmaceutical Sales by Application

8 Asia-Pacific

  • 8.1 Asia-Pacific Radiopharmaceutical Market Size YoY Growth 2015-2026
  • 8.2 Asia-Pacific Radiopharmaceutical Market Facts & Figures by Region
    • 8.2.1 Asia-Pacific Radiopharmaceutical Sales by Region (2015-2026)
    • 8.2.2 Asia-Pacific Radiopharmaceutical Revenue by Region (2015-2026)
  • 8.3 Asia-Pacific Radiopharmaceutical Sales by Type
  • 8.4 Asia-Pacific Radiopharmaceutical Sales by Application

9 Europe

  • 9.1 Europe Radiopharmaceutical Market Size YoY Growth 2015-2026
  • 9.2 Europe Radiopharmaceutical Market Facts & Figures by Country
    • 9.2.1 Europe Radiopharmaceutical Sales by Country (2015-2026)
    • 9.2.2 Europe Radiopharmaceutical Revenue by Country (2015-2026)
  • 9.3 Europe Radiopharmaceutical Sales by Type
  • 9.4 Europe Radiopharmaceutical Sales by Application

10 Latin America

  • 10.1 Latin America Radiopharmaceutical Market Size YoY Growth 2015-2026
  • 10.2 Latin America Radiopharmaceutical Market Facts & Figures by Country
    • 10.2.1 Latin America Radiopharmaceutical Sales by Country (2015-2026)
    • 10.2.2 Latin America Radiopharmaceutical Revenue by Country (2015-2026)
  • 10.3 Latin America Radiopharmaceutical Sales by Type
  • 10.4 Latin America Radiopharmaceutical Sales by Application

11 Middle East and Africa

  • 11.1 Middle East and Africa Radiopharmaceutical Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Radiopharmaceutical Sales by Country (2015-2026)
    • 11.2.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2015-2026)
  • 11.3 Middle East and Africa Radiopharmaceutical Sales by Type
  • 11.4 Middle East and Africa Radiopharmaceutical Sales by Application

12 Supply Chain and Sales Channel Analysis

  • 12.1 Radiopharmaceutical Supply Chain Analysis
  • 12.2 Radiopharmaceutical Key Raw Materials and Upstream Suppliers
  • 12.3 Radiopharmaceutical Clients Analysis
  • 12.4 Radiopharmaceutical Sales Channel and Sales Model Analysis
    • 12.4.1 Radiopharmaceutical Distribution Channel Analysis: Indirect Sales VS Direct Sales
    • 12.4.2 Radiopharmaceutical Distribution Channel Analysis: Online Sales VS Offline Sales
    • 12.4.3 Radiopharmaceutical Distributors

13 Market Dynamics

  • 13.1 Radiopharmaceutical Market Drivers
  • 13.2 Radiopharmaceutical Market Opportunities
  • 13.3 Radiopharmaceutical Market Challenges
  • 13.4 Radiopharmaceutical Market Restraints
  • 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Radiopharmaceutical market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Radiopharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

    Segment by Type, the Radiopharmaceutical market is segmented into
    Actinium-225
    Lutetium-177
    Radium-223
    Holmium-166
    Other

    Segment by Application, the Radiopharmaceutical market is segmented into
    Oncology
    Cardiology
    Other

    Regional and Country-level Analysis:
    North America
    United States
    Canada
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Southeast Asia
    Australia
    Rest of Asia-Pacific
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic Countries
    Rest of Europe
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    Competitive Landscape and Radiopharmaceutical Market Share Analysis
    Radiopharmaceutical market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Radiopharmaceutical product introduction, recent developments, Radiopharmaceutical sales by region, type, application and by sales channel.

    The major companies include:
    Bracco Imaging
    Bayer
    Mallinckrodt
    Nordion
    Triad Isotopes
    Lantheus
    IBA Group
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Advanced Accelerator Applications
    SIEMENS
    Dongcheng
    Navidea

    Buy now